<SEC-DOCUMENT>0001493152-25-018269-index.html : 20251016 <SEC-HEADER>0001493152-25-018269.hdr.sgml : 20251016 <ACCEPTANCE-DATETIME>20251016092026 ACCESSION NUMBER: 0001493152-25-018269 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 20 CONFORMED PERIOD OF REPORT: 20251014 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 251396617 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8-k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: form8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex5-1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>ex10-1.htm <DESCRIPTION>EX-10.1 <TEXT> Document 3 - file: ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>ex10-2.htm <DESCRIPTION>EX-10.2 <TEXT> Document 4 - file: ex10-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>5 <FILENAME>ex10-3.htm <DESCRIPTION>EX-10.3 <TEXT> Document 5 - file: ex10-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>6 <FILENAME>ex10-4.htm <DESCRIPTION>EX-10.4 <TEXT> Document 6 - file: ex10-4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.5 <SEQUENCE>7 <FILENAME>ex10-5.htm <DESCRIPTION>EX-10.5 <TEXT> Document 7 - file: ex10-5.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex5-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: ex5-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>9 <FILENAME>aktx-20251014.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 9 - file: aktx-20251014.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>10 <FILENAME>aktx-20251014_def.xml <DESCRIPTION>XBRL DEFINITION FILE <TEXT> Document 10 - file: aktx-20251014_def.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>11 <FILENAME>aktx-20251014_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 11 - file: aktx-20251014_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>12 <FILENAME>aktx-20251014_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 12 - file: aktx-20251014_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>18 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: FilingSummary.html
Document 18 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>20 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 20 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>21 <FILENAME>0001493152-25-018269-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 21 - file: 0001493152-25-018269-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>22 <FILENAME>form8-k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 22 - file: form8-k_htm.html
Document 22 - RAW XML: form8-k_htm.xml
</DOCUMENT> </SEC-DOCUMENT>